RETRACTED: Preparation and Optimization of Hydrophilic Modified Pullulan Encapsulated Tetracycline for Significant Antibacterial and Anti‐Biofilm Activity Against Stenotrophomonas maltophilia Isolates
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202402252 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Mahtab Asgari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Stenotrophomonas maltophilia, Biofilms, Glucans, Anti-Bacterial Agents. Die Arbeit nennt 52 Literaturangaben.
Abstract (Originalsprache)
Stenotrophomonas maltophilia ( S. maltophilia ), resistant to antibiotics, is a hazardous illness and a well‐known worldwide public health issue. The present investigation included the preparation of formulations of tetracycline encapsulated in pullulan (referred to as HM‐PULL‐Tetracycline). The study aimed to assess the effectiveness of these formulations against strains of S. maltophilia in terms of their antimicrobial and anti‐biofilm properties. The physicochemical characteristics of HM‐PULL‐Tetracycline were analyzed using a field scanning electron microscope, X‐ray dispersion, Zeta potential, and dynamic light scattering analysis. The antibacterial and anti‐biofilm activity was assessed using minimal biofilm inhibitory concentration and broth micro‐dilution. In addition, the biocompatibility of HM‐PULL‐Tetracycline was assessed by investigating its cytotoxicity on the human diploid fibroblasts (HDF) normal cell line using the MTT test. The HM‐PULL‐Tetracycline formulation successfully prevented biofilm formation, measuring 179.7±2.66 nm in size and with an encapsulation efficiency of 84.86±3.14 %. It exhibited a biofilm growth inhibition rating of 69 % and significantly down‐regulated the expression of the smf‐1 , rpfF , rmlA , and spgM biofilm genes in S. maltophilia strains (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Microbiology, Faculty of Biological Sciences, Falavarjan Branch, Islamic Azad University, Isfahan, Iran.
- Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran.
- Biotechnology Research Center, Islamic Azad University, East-Tehran Branch, Tehran, Iran.
- Department of Microbiology, Young Researchers and Elite Club, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
- Department of Microbiology, Faculty of Biological Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
Zitieren
APA
Asgari, M., Rezaeizadeh, G., Ghajari, G., Azami, Z., Behshood, P., Talebi, F., & Piri Gharaghie, T. (2024). RETRACTED: Preparation and Optimization of Hydrophilic Modified Pullulan Encapsulated Tetracycline for Significant Antibacterial and Anti‐Biofilm Activity Against Stenotrophomonas maltophilia Isolates. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402252
Vancouver
Asgari M, Rezaeizadeh G, Ghajari G, Azami Z, Behshood P, Talebi F, et al. RETRACTED: Preparation and Optimization of Hydrophilic Modified Pullulan Encapsulated Tetracycline for Significant Antibacterial and Anti‐Biofilm Activity Against Stenotrophomonas maltophilia Isolates. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202402252
BibTeX
@article{Asgari2024,
author = {Asgari, Mahtab and Rezaeizadeh, Golnoosh and Ghajari, Ghazal and Azami, Zahra and Behshood, Parisa and Talebi, Fatemeh and Piri Gharaghie, Tohid},
title = {RETRACTED: Preparation and Optimization of Hydrophilic Modified Pullulan Encapsulated Tetracycline for Significant Antibacterial and Anti‐Biofilm Activity Against Stenotrophomonas maltophilia Isolates},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202402252}
}
EUVIMED